Research progress on the association between inflammatory factors and myopia

FENG Mian; XU Shaojun; SU Yu; TAO Fangbiao

doi:10.16835/j.cnki.1000-9817.2025306

Volume 46 Issue 10

Oct. 2025

Turn off MathJax

Article Contents

Article Navigation > CHINESE JOURNAL OF SCHOOL HEALTH > 2025 > 46(10): 1503-1505

FENG Mian, XU Shaojun, SU Yu, TAO Fangbiao. Research progress on the association between inflammatory factors and myopia[J]. CHINESE JOURNAL OF SCHOOL HEALTH, 2025, 46(10): 1503-1505. doi: 10.16835/j.cnki.1000-9817.2025306

Citation:

FENG Mian, XU Shaojun, SU Yu, TAO Fangbiao. Research progress on the association between inflammatory factors and myopia[J]. CHINESE JOURNAL OF SCHOOL HEALTH, 2025, 46(10): 1503-1505. doi: 10.16835/j.cnki.1000-9817.2025306

Citation:

PDF( 978 KB)

Research progress on the association between inflammatory factors and myopia

doi: 10.16835/j.cnki.1000-9817.2025306

1.
Department of Maternal, Child & Adolescent Health, School of Public Health, Anhui Medical University/MOE Key Laboratory of Population Health across Life Cycle/Anhui Provincial Key Laboratory of Environment and Population Health across the Life Course, Hefei 230032, Anhui Province, China

Received Date: 2025-07-30
Rev Recd Date: 2025-09-11
Publish Date: 2025-10-25

Abstract

Abstract

The etiology and pathogenesis of myopia among children and adolescents remain unclear. As crucial regulatory mediators in the body, inflammatory cytokines have drawn increasing attention for their potential role in the onset and progression of myopia. The study examines the relationship between systemic inflammation and intraocular inflammation and myopia, explores the inflammatory mechanisms underlying myopia development, and discusses intervention strategies targeting related signaling pathways for myopia treatment. It aims to provide new insights for the prevention and control of myopia in children and adolescents.
- Chemokines,
- Myopia,
- Research,
- Health promotion

FullText(HTML)

References(32)

References

[1]	HOLDEN B A, FRICKE T R, WILSON D A, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050[J]. Ophthalmology, 2016, 123(5): 1036-1042.
[2]	GRZYBOWSKI A, KANCLERZ P, TSUBOTA K, et al. A review on the epidemiology of myopia in school children worldwide[J]. BMC Ophthalmol, 2020, 20(1): 27.
[3]	WILLIAMS K M, HAMMOND C J. Perspectives on genetic and environmental factors in myopia, its prediction, and the future direction of research[J]. Invest Ophthalmol Vis Sci, 2025, 66(7): 4.
[4]	XU R, ZHENG J, LIU L, et al. Effects of inflammation on myopia: evidence and potential mechanisms[J]. Front Immunol, 2023, 14: 1260592.
[5]	LIN H J, WEI C C, CHANG C Y, et al. Role of chronic inflammation in myopia progression: clinical evidence and experimental validation[J]. EBioMedicine, 2016, 10: 269-281.
[6]	YUAN J, WU S, WANG Y, et al. Inflammatory cytokines in highly myopic eyes[J]. Sci Rep, 2019, 9(1): 3517.
[7]	XIN J, BAO B, LIU J, et al. Crosstalk between myopia and inflammation: a mini review[J]. Int J Med Sci, 2024, 21(9): 1589-1603.
[8]	HUANG Z, ZHOU J, LIU S, et al. The interplay between systemic inflammation and myopia: a bidirectional Mendelian randomization and experimental validation study[J]. Int Immunopharmacol, 2025, 157: 114803.
[9]	KANG Y T, ZHUANG Z H, HE X, et al. Mendelian randomization supports causal effects of inflammatory biomarkers on myopic refractive errors[J]. Eur J Ophthalmol, 2025, 35(2): 400-408.
[10]	LONG Q, YE J, LI Y, et al. C-reactive protein and complement components in patients with pathological myopia[J]. Optom Vis Sci, 2013, 90(5): 501-506.
[11]	HAN S B, JANG J, YANG H K, et al. Prevalence and risk factors of myopia in adult Korean population: Korea national health and nutrition examination survey 2013-2014 (KNHANES VI)[J]. PLoS One, 2019, 14(1): e0211204.
[12]	ICEL E, UCAK T, KARAKURT Y, et al. The relation of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio with high axial myopia[J]. Ocul Immunol Inflamm, 2020, 28(3): 396-401.
[13]	WANG X, HE Q, ZHAO X, et al. Assessment of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with high myopia[J]. BMC Ophthalmol, 2022, 22(1): 464.
[14]	YE S, HOU X, SONG K, et al. Association between dietary inflammatory index and adolescent myopia based on the National Health and Nutrition Examination Survey[J]. Sci Rep, 2024, 14(1): 28048.
[15]	YU Q, WANG C, LIU Z, et al. Association between inflammatory cytokines and oxidative stress levels in aqueous humor with axial length in human myopia[J]. Exp Eye Res, 2023, 237: 109670.
[16]	DE PIANO M, CACCIAMANI A, BALZAMINO B O, et al. Biomarker signature in aqueous humor mirrors lens epithelial cell activation: new biomolecular aspects from cataractogenic myopia[J]. Biomolecules, 2023, 13(9): 1328.
[17]	WEI Q, ZHUANG X, FAN J, et al. Proinflammatory and angiogenesis-related cytokines in vitreous samples of highly myopic patients[J]. Cytokine, 2021, 137: 155308.
[18]	NISHANTH S, BAUER N J C, SHETTY R, et al. A novel comparative study of inflammatory cytokines through noninvasive tear analysis in children with myopia versus emmetropia[J]. Am J Ophthalmol, 2025, 278: 413-420.
[19]	LIANG R, LI T, GAO H, et al. Causal relationships between inflammatory cytokines and myopia: an analysis of genetic and observational studies[J]. Ann Med Surg, 2024, 86(9): 5179-5190.
[20]	MCBRIEN N A. Regulation of scleral metabolism in myopia and the role of transforming growth factor-beta[J]. Exp Eye Res, 2013, 114: 128-140.
[21]	YU Q, ZHOU J B. Scleral remodeling in myopia development[J]. Int J Ophthalmol, 2022, 15(3): 510-514.
[22]	ZHAO F, ZHOU Q, REINACH P S, et al. Cause and effect relationship between changes in scleral matrix metallopeptidase-2 expression and myopia development in mice[J]. Am J Pathol, 2018, 188(8): 1754-1767.
[23]	IKEDA S I, KURIHARA T, TODA M, et al. Oral bovine milk lactoferrin administration suppressed myopia development through matrix metalloproteinase 2 in a mouse model[J]. Nutrients, 2020, 12(12). DOI: 10.3390/nu12123744.
[24]	LIU L, ZHOU W, FAN Y, et al. Effect of interleukin 6 on scleral fibroblast proliferation, differentiation, and apoptosis involved in myopic scleral remodeling[J]. Ophthalmic Res, 2022, 65(5): 529-539.
[25]	KU H, CHEN J J, HU M, et al. Myopia development in tree shrew is associated with chronic inflammatory reactions[J]. Curr Issues Mol Biol, 2022, 44(9): 4303-4313.
[26]	KU H, CHEN J J, CHEN W, et al. The role of transforming growth factor beta in myopia development[J]. Mol Immunol, 2024, 167: 34-42.
[27]	CHEN Z, XIAO K, LONG Q. Up-regulation of NLRP3 in the sclera correlates with myopia progression in a form-deprivation myopia mouse model[J]. Front Biosci, 2023, 28(2): 27.
[28]	XIAO K, CHEN Z, HE S, et al. Up-regulation of scleral C5b-9 and its regulation of the NLRP3 inflammasome in a form-deprivation myopia mouse model[J]. Immunobiology, 2024, 229(1): 152776.
[29]	CHOU Y L, HSU Y A, LIN C F, et al. Complement decay-accelerating factor inhibits inflammation-induced myopia development[J]. Mol Immunol, 2024, 171: 47-55.
[30]	CHEN C S, HSU Y A, LIN C H, et al. Fallopia Japonica and Prunella vulgaris inhibit myopia progression by suppressing AKT and NFκB mediated inflammatory reactions[J]. BMC Complement Med Ther, 2022, 22(1): 271.
[31]	HSU Y A, CHEN C S, WANG Y C, et al. Anti-inflammatory effects of resveratrol on human retinal pigment cells and a myopia animal model[J]. Curr Issues Mol Biol, 2021, 43(2): 716-727.
[32]	TIEN P T, LIN C H, CHEN C S, et al. Diacerein inhibits myopia progression through lowering inflammation in retinal pigment epithelial cell[J]. Mediators Inflamm, 2021, 2021: 6660640.